ADC Archives | Page 2 of 2 | Certara

Publication

A Sequential Population Pharmacokinetic Model of Zilovertamab Vedotin in Patients with Hematologic Malignancies Extrapolated to the Pediatric Population

CertaraNovember 7, 2024

Sutro Biopharma

Case Study

Model-Informed Confidence in Oncology Dose Selection

Discover an oncology-focused company that gained confidence in their dose selection for an AML trial…

CertaraAugust 9, 2024

© 2026 Certara. All Rights Reserved. | Legal | Privacy policy